| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/05/2005 | CN1559411A Application of stable thiabutyldine quinoline carboxylate in preparing anti-infective |
| 01/05/2005 | CN1559410A Itraconazole soft capsule, and its prepn. method |
| 01/05/2005 | CN1559409A Compound prepn. contg. Brufen arginine codeine |
| 01/05/2005 | CN1559408A Leurocristine sulfate liposome compositions, and its prepn. method |
| 01/05/2005 | CN1559407A Self-micro emulsion solft capsule of dihydropyridine type calcium ion agonist, and its prepn. method |
| 01/05/2005 | CN1559406A Series medicine prepn. contg. tinidazole used as compound for anti-trichomoniasis and anti-anaerobic former |
| 01/05/2005 | CN1559405A Solid prepn. of sodium vitamin C for injection and its prepn. method |
| 01/05/2005 | CN1559404A Method for preparing artemisine and its liposoluble derivatives emulsion |
| 01/05/2005 | CN1559403A Method for preparing soft capsule prepn. contg. artemisine |
| 01/05/2005 | CN1559402A Novel use of Brazil Hematine red |
| 01/05/2005 | CN1559401A Therapeutic use and compositions involving isoflavones |
| 01/05/2005 | CN1559400A Method for preparing scutellarein liquid |
| 01/05/2005 | CN1559399A Injection of haw leaf flavone prepn. method and use thereof |
| 01/05/2005 | CN1559398A Application of chalcone for preparing medicnes for treating hepatitis and hepatoma |
| 01/05/2005 | CN1559397A Chrono-slow-releasing prepn. hydrochloride verapamil |
| 01/05/2005 | CN1559396A Somatostat in prepn. for injection use, and its prepn. method |
| 01/05/2005 | CN1559395A Freezing-drying compound contg. water-soluble gallopropylate and its prepn. method |
| 01/05/2005 | CN1559394A Compound prepn. for lowering blood-sugar, and its use |
| 01/05/2005 | CN1559393A Freezing-drying sterile prepn. used for injection contg. sodium naproxen |
| 01/05/2005 | CN1559392A Applicaton of gallic acid in prepn. of medicine for antitumor |
| 01/05/2005 | CN1559391A Volume-expansion protection agent, and application in treating blood-loss shock |
| 01/05/2005 | CN1559390A Oral disintegration tablets contg. p-acetaminophenol, and prepn. method therefor |
| 01/05/2005 | CN1559389A Levo-salbutamol sulfate inhaler, and its prepn. method |
| 01/05/2005 | CN1559388A Tramadol hydrochloride oral disintegration tablets, and prepn. method therefor |
| 01/05/2005 | CN1559387A Intravenous injection liquid of coenzyme Q10, and its prepn. method |
| 01/05/2005 | CN1559386A Method for preparing emodin liquid |
| 01/05/2005 | CN1559385A Probucol solid dispersion tablets, and prepn. method therefor |
| 01/05/2005 | CN1183753C Time and location-driven personalized TV |
| 01/05/2005 | CN1183162C Antitumor carboxyalkyl achyranthis polysaccharide and its preparation method and use |
| 01/05/2005 | CN1183156C Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 01/05/2005 | CN1183154C Solid dispersion containing sialic acid derivative |
| 01/05/2005 | CN1183153C Orally active a1 adenosine receptor agonists |
| 01/05/2005 | CN1183151C Spherical telithroimycikn clusters, method for the production and use thereof in the preparation of pharmaceutical forms |
| 01/05/2005 | CN1183149C Pharmaceutical compositions containing oligosaccharides and preparation thereof |
| 01/05/2005 | CN1183148C Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium 2.5 hydrate or monohydrate |
| 01/05/2005 | CN1183147C Diphosphonic acid derivant and preparation process and application thereof |
| 01/05/2005 | CN1183142C Cynnematin kind antibiotics and composite and use |
| 01/05/2005 | CN1183141C Vinyl-pyrrolidone cynnematin with alkali substituent |
| 01/05/2005 | CN1183136C Indoloquinazolinones |
| 01/05/2005 | CN1183135C A novel crystalline form pyrrolo [2,3-d] pyrimidine antifolic agent and process therefor |
| 01/05/2005 | CN1183134C Tricyclic vasporessin agonists |
| 01/05/2005 | CN1183133C 2-amino-6-anilino-purines and their use as medicaments |
| 01/05/2005 | CN1183132C Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 01/05/2005 | CN1183130C Thiazolidine derivatives and medicinal application thereof |
| 01/05/2005 | CN1183129C Condensed azepines as vasporession agonists |
| 01/05/2005 | CN1183128C N-(heterocyclic)-benzene or pyridine sulphozmides as antithrombotic agents and anticoagulants |
| 01/05/2005 | CN1183127C Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 01/05/2005 | CN1183126C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 01/05/2005 | CN1183122C Dipeptide nitrile cathepsin K inhibitors |
| 01/05/2005 | CN1183119C Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use |
| 01/05/2005 | CN1183116C Substituted isoquinoline derivatives and pharmaceutical composition containing them, its preparation method and use |
| 01/05/2005 | CN1183115C 5-amino-8-methoxy quinolone carboxylic acid derivatives and its preparation |
| 01/05/2005 | CN1183113C Tri-aryl acid derivatives as PPAR receptor ligands |
| 01/05/2005 | CN1183111C Cycloalkano-indole and cycloalkane-azaindole derivatives, process for their preparation and pharmaceutical commposition containing the same |
| 01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 01/05/2005 | CN1183101C Derivatives of alpha-amino acid phenyl ester |
| 01/05/2005 | CN1183098C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 01/05/2005 | CN1183097C Benflumetol, intermediates thereof and their use against parasitical protozoa and trematodes |
| 01/05/2005 | CN1182904C Methods for extraction and reaction using supercritical fluids |
| 01/05/2005 | CN1182873C Arginine silicate inositol complex and use thereof |
| 01/05/2005 | CN1182872C Use of (meth) acrylic acid copolymers to increase permeability of mucous membranes |
| 01/05/2005 | CN1182870C Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 01/05/2005 | CN1182869C Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restemosis |
| 01/05/2005 | CN1182856C External medicine for treating mastopathy and its prepn process |
| 01/05/2005 | CN1182854C Chinese medicine liquor for curing pointed condyloma and its preparation method |
| 01/05/2005 | CN1182851C Compound extracted from effective part of influenze virus resisting medicine |
| 01/05/2005 | CN1182850C Preparation capable of regulating blood fat, blood pressure and blood sugar for protecting heart and brain cells and its prearing method |
| 01/05/2005 | CN1182849C Freeze dried hydroxycamptothecin powder injection and its preparing process |
| 01/05/2005 | CN1182848C Application of brataxin in preparation of medicine for inhibiting AIDS virus |
| 01/05/2005 | CN1182847C Combination of selective 5-HTIA antagonist and selective h5-HTIB antagonist or partial agonist |
| 01/05/2005 | CN1182846C Water soluble anticancer medicine taxol composite and its prepn method |
| 01/05/2005 | CN1182845C Anticonvulsant derivatives for treating cluster headaches |
| 01/05/2005 | CN1182844C Use of dialkylfumarates |
| 01/05/2005 | CN1182843C Use of trans-diphenylethene derivs in preventing or treating liver fibrosis |
| 01/05/2005 | CN1182842C Soft gelatin capsule and its manufacture method |
| 01/05/2005 | CN1182841C New pharmaceutical formulation and preparation process |
| 01/05/2005 | CN1182840C Coated medicament forms with controlled active substance release |
| 01/05/2005 | CN1182839C Ascending-dose dosage form |
| 01/05/2005 | CN1182837C Orally administrable immediate and prolonged-release Galenic form comprising absorption-promoting agent and use of this absorption-promoting agent |
| 01/05/2005 | CN1182832C Composition for making unstable material of oxygen stabilize |
| 01/05/2005 | CN1182831C Synergistic antibacterial combination |
| 01/04/2005 | US6839604 Compliance tracking method |
| 01/04/2005 | US6838584 Estrogen receptor modulators |
| 01/04/2005 | US6838583 Cleaning compound, dentifrices; reducing microorganisms |
| 01/04/2005 | US6838580 Opioid derivative |
| 01/04/2005 | US6838562 Salt formation of creatine and orotic acid; water solubility, stability, bioavailability |
| 01/04/2005 | US6838559 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease |
| 01/04/2005 | US6838558 Useful in the treatment and control of solid tumors |
| 01/04/2005 | US6838552 Diagnosis and management of infection caused by Chlamydia |
| 01/04/2005 | US6838547 Acryloyl derivatives of distamycin conjugated with glutathione; have antitumor activity and are thus useful in therapy in the treatment of cancer |
| 01/04/2005 | US6838528 Absorption, bioavailability |
| 01/04/2005 | US6838484 Androgen receptor targeting agents which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor |
| 01/04/2005 | US6838482 Fungicidal composition |
| 01/04/2005 | US6838481 Blocking melanin biosynthesis; side effect reduction |
| 01/04/2005 | US6838480 Composition containing sucrafate and a topical anesthetic for humans and animals and method of use thereof |
| 01/04/2005 | US6838479 Amidine inhibitors of serine proteases |
| 01/04/2005 | US6838477 Lactacystin analogs |
| 01/04/2005 | US6838476 Imidazoles with anti-inflammatory activity |
| 01/04/2005 | US6838475 For prophylaxis and therapy of one or more symptoms of hepatitis C |
| 01/04/2005 | US6838474 Prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. This invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and |